1. Home
  2. ELDN vs WILC Comparison

ELDN vs WILC Comparison

Compare ELDN & WILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • WILC
  • Stock Information
  • Founded
  • ELDN 2004
  • WILC 1994
  • Country
  • ELDN United States
  • WILC Israel
  • Employees
  • ELDN 31
  • WILC N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • WILC Food Distributors
  • Sector
  • ELDN Health Care
  • WILC Consumer Discretionary
  • Exchange
  • ELDN Nasdaq
  • WILC Nasdaq
  • Market Cap
  • ELDN 176.1M
  • WILC 201.1M
  • IPO Year
  • ELDN N/A
  • WILC 1997
  • Fundamental
  • Price
  • ELDN $2.99
  • WILC $14.93
  • Analyst Decision
  • ELDN Strong Buy
  • WILC
  • Analyst Count
  • ELDN 1
  • WILC 0
  • Target Price
  • ELDN $16.00
  • WILC N/A
  • AVG Volume (30 Days)
  • ELDN 249.0K
  • WILC 15.8K
  • Earning Date
  • ELDN 05-08-2025
  • WILC 05-19-2025
  • Dividend Yield
  • ELDN N/A
  • WILC 3.90%
  • EPS Growth
  • ELDN N/A
  • WILC 122.00
  • EPS
  • ELDN N/A
  • WILC 1.39
  • Revenue
  • ELDN N/A
  • WILC $158,085,550.00
  • Revenue This Year
  • ELDN N/A
  • WILC N/A
  • Revenue Next Year
  • ELDN N/A
  • WILC N/A
  • P/E Ratio
  • ELDN N/A
  • WILC $10.73
  • Revenue Growth
  • ELDN N/A
  • WILC 5.99
  • 52 Week Low
  • ELDN $1.55
  • WILC $8.18
  • 52 Week High
  • ELDN $5.54
  • WILC $17.58
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 39.03
  • WILC 45.82
  • Support Level
  • ELDN $2.63
  • WILC $13.40
  • Resistance Level
  • ELDN $3.21
  • WILC $15.30
  • Average True Range (ATR)
  • ELDN 0.24
  • WILC 1.06
  • MACD
  • ELDN 0.03
  • WILC 0.06
  • Stochastic Oscillator
  • ELDN 45.24
  • WILC 79.67

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About WILC G. Willi-Food International Ltd.

G. Willi-Food International Ltd is a company engaged in high-quality, great-tasting kosher food products. The Company is engaged, directly and through subsidiaries, with one segment Import-export, marketing, and distribution of food products. The principal product line includes Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Dried Fruit, Nuts and Beans, and Other Products. Its brands include Willi-Food, Euro European Dairies, Donna Rozza, Manchow, Gold Frost, Tifeeret, The Chef Dish, Art Coffe, Mr. Chang, Muchi, Euro Butter, Euro Spread, Euro Cheese, Euro Cream, Euro Dessert, Euro Veg, Ha-Bulgaria, Gelato, and Emma.

Share on Social Networks: